Fox Run Management’s Select Medical SEM Stock Holding History

Fox Run Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-82,473	Closed	-$1.22M	–	1202
2025 Q4	$1.22M	Buy	82,473 +50,694	+160%	+$716K	0.19%	133
2025 Q3	$408K	Sell	31,779 -29,560	-48%	-$394K	0.06%	577
2025 Q2	$931K	Buy	+61,339	New	+$957K	0.16%	213
2024 Q3	–	Sell	-18,493	Closed	-$349K	–	1070
2024 Q2	$349K	Buy	+18,493	New	+$315K	0.07%	518
2023 Q4	–	Sell	-25,681	Closed	-$350K	–	992
2023 Q3	$350K	Buy	+25,681	New	+$397K	0.1%	385
2019 Q3	–	Sell	-36,654	Closed	-$313K	–	540
2019 Q2	$313K	Buy	+36,654	New	+$290K	0.21%	214
2019 Q1	–	Sell	-29,750	Closed	-$246K	–	666
2018 Q4	$246K	Buy	+29,750	New	+$285K	0.13%	339
2018 Q2	–	Sell	-69,117	Closed	-$642K	–	887
2018 Q1	$642K	Sell	69,117 -18,486	-21%	-$176K	0.16%	229
2017 Q4	$833K	Buy	+87,603	New	+$837K	0.24%	104
2017 Q1	–	Sell	-18,931	Closed	-$135K	–	728
2016 Q4	$135K	Buy	+18,931	New	+$132K	0.07%	457

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fox Run Management's SEM Position: Q1 2026 in Review

Fox Run Management sold out of Select Medical (SEM) in Q1 2026, closing a stake of 82,473 shares — an estimated $1.22M sold.

Fox Run Management first reported a position in SEM in Q4 2016 and held it in 10 quarters. The position peaked at $1.22M in Q4 2025. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

Fox Run Management reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
Fox Run Management sold 82,473 Select Medical shares in Q1 2026, an estimated $1.22M.
Fox Run Management first reported a position in Select Medical in Q4 2016 and held it in 10 quarters.
Fox Run Management's Select Medical position peaked at $1.22M in Q4 2025.
278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.